Imaging of Liver and Spleen Morphology
暂无分享,去创建一个
[1] M. Mirza,et al. Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. , 1976, Annals of internal medicine.
[2] Wiklund Ra,et al. First of two parts , 1997 .
[3] L. Krulich,et al. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. , 1968, Endocrinology.
[4] R. Jeffrey,et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. , 1993, Radiology.
[5] D. Marks,et al. Ultrasonic features and radionuclide correlation in liver cell adenoma and focal nodular hyperlasia. , 1980, Radiology.
[6] P. Sheedy,et al. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. , 1985, Radiology.
[7] S. Reichlin. Somatostatin. , 1983, The New England journal of medicine.
[8] J. Selby. Nuclear Medicine Annual, 1995 , 1996 .
[9] G. Glazer,et al. The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. , 1987, Radiographics : a review publication of the Radiological Society of North America, Inc.
[10] Milton J. Finegold. Tumors of the Liver , 1994, Seminars in liver disease.
[11] P. Hoffer,et al. The use of inspiration-expiration scintiphotographs to determine the intrinsic or extrinsic nature of liver defects. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] D. Venzon,et al. Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study , 1996, Annals of Internal Medicine.
[13] A. Gottschalk,et al. Diagnostic significance of the relative uptake of liver compared with spleen in 99mTc-sulfur colloid scintiphotography. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Eva Forssell-Aronsson,et al. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] M. Thelen,et al. Focal nodular hyperplasia of the liver as established by 99mTc sulfur colloid and HIDA scintigraphy. , 1980, Radiology.
[16] H. Wagner,et al. DIAGNOSTIC VALUE OF SCINTILLATION SCANNING OF THE LIVER. , 1965, Archives of internal medicine.
[17] T. Shawker,et al. A Prospective Analysis of Laboratory Tests and Imaging Studies To Detect Hepatic Lesions , 1982, Annals of surgery.
[18] R. Howman-Giles,et al. TI-201 positive, Ga-67 negative hepatoblastoma : A case report of a 12-year-old boy , 1997 .
[19] S. Reichlin. Somatostatin (First of two parts) , 1983 .
[20] A. Megibow,et al. Observations on the growth of renal neoplasms. , 1990, Radiology.
[21] K. Endo,et al. Radiation dosimetry for indium-111-pentetreotide. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] W. Blahd,et al. Diagnosis of hepatic hemangioma using multiple-radionuclide and ultrasound techniques. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J. Doppman,et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. , 1997, Gastroenterology.
[24] N. Shuke,et al. Focal nodular hyperplasia of the liver: scintigraphic demonstration using three hepatic imaging agents. , 1999, Clinical nuclear medicine.
[25] D. Becker,et al. Evaluation of spleen size during routine liver imaging with 99mTc and the scintillation camera. , 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] J. Doppman,et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] S. Sherlock,et al. Diseases of the Liver and Biliary System , 1955 .
[28] K. Suga,et al. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. , 1997, Clinical nuclear medicine.
[29] A. Rahmouni,et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] A. Zucker. CURABILITY OF BREAST CANCER , 1975, The Lancet.
[31] A. Megibow,et al. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. , 1990, Radiology.
[32] E. P. Krenning,et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients , 1993, European Journal of Nuclear Medicine.
[33] E. P. Krenning,et al. LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN , 1989, The Lancet.
[34] A. Maurer,et al. Hepatic cavernous hemangioma: diagnosis with 99mTc-labeled red cells and single-photon emission CT. , 1987, AJR. American journal of roentgenology.
[35] M. Sinanan,et al. Management of cavernous hemangioma of the liver. , 1989, American journal of surgery.
[36] J. Quinn. Nuclear Medicine in Gastroenterology , 1972 .
[37] K. Ishak,et al. Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. , 1987, AJR. American journal of roentgenology.
[38] M. Salvatore,et al. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. , 1997, The New England journal of medicine.
[39] T. Waldmann,et al. α-Fetoprotein in Nonneoplastic Hepatic Disorders , 1975 .
[40] T. Mcgarrity,et al. An analysis of imaging studies and liver function tests to detect hepatic neoplasia , 1987, Digestive Diseases and Sciences.
[41] R. Peters,et al. Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .
[42] J. Fletcher,et al. Xenon-133 accumulation in hepatic steatosis. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] G. Denardo,et al. Hepatic scintiangiographic patterns. , 1974, Radiology.
[44] L. Kvols,et al. Distribution of somatostatin receptors in normal and tumor tissue. , 1990, Metabolism: clinical and experimental.
[45] B. J. McConnell,et al. 133xe uptake in focal hepatic fat accumulation: CT correlation. , 1982, AJR. American journal of roentgenology.
[46] Harlan I. Firminger,et al. Atlas of tumor pathology , 1954 .
[47] D. Knowles,et al. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. , 1976, Human pathology.
[48] E P Krenning,et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[49] K. Ishak,et al. Benign tumors of the liver. , 1975, The Medical clinics of North America.
[50] Possible association between benign hepatomas and oral contraceptives. , 1973 .
[51] E. McClees,et al. Screening for Diffuse and Focal Liver Disease: The Case for Hepatic Scintigraphy , 1984, Journal of clinical ultrasound : JCU.
[52] Keyes Jw,et al. An Evaluation of Lung Uptake of Colloid During Liver Imaging , 1973 .
[53] S. A. Rabinowitz,et al. 99mTc red blood cell scintigraphy in evaluating focal liver lesions. , 1984, AJR. American journal of roentgenology.
[54] C. Degott,et al. Liver adenomatosis. An entity distinct from liver adenoma? , 1985, Gastroenterology.
[55] B J McNeil,et al. Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. , 1983, Radiology.
[56] B B Gosink,et al. Characteristic sonographic signs of hepatic fatty infiltration. , 1985, AJR. American journal of roentgenology.
[57] S. Vallabhajosula,et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[58] F. Jamar,et al. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] E. Krenning,et al. Somatostatin receptor imaging for neuroendocrine tumors , 2006, Pituitary.
[60] A. Gimson,et al. Focal nodular hyperplasia of the liver: results of treatment and options in management. , 1991, Gut.
[61] J. Drouillard,et al. Single photon emission computed tomography (SPECT), planar scintigraphy, and transmission computed tomography: a comparison of accuracy in diagnosing focal hepatic disease. , 1984, Radiology.
[62] Y. Sugiyama,et al. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. , 1996, The Journal of pharmacology and experimental therapeutics.
[63] P. Sones,et al. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. , 1981, AJR. American journal of roentgenology.
[64] L. Kvols,et al. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. , 1993, Radiology.
[65] S. Othman,et al. Features of hepatic cavernous hemangioma on planar and SPECT Tc-99m-labeled red blood cell scintigraphy. , 1999, Clinical nuclear medicine.
[66] R. Mould. An investigation of the variations in normal liver shape. , 1972, British Journal of Radiology.
[67] M. Rehling,et al. Somatostatin Receptor Scintigraphy , 1999 .
[68] H. Meltzer,et al. Hypercortisolism and depression. , 1985, The New England journal of medicine.
[69] Rapid evaluation of hepatic size on radioisotope scan. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] P. Angelberger,et al. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[71] J. Drouillard,et al. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. , 1986, Radiology.
[72] T. Waldmann,et al. alpha-fetoprotein in noneoplastic hepatic disorders. , 1975, JAMA.
[73] V. Sansalone,et al. Surgical treatment of symptomatic giant hemangiomas of the liver. , 1992, Surgery, gynecology & obstetrics.
[74] M. Lapiński,et al. Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives. , 1975, Annals of internal medicine.